KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Sales and Divestitures (2016 - 2022)

Historic Gains from Sales and Divestitures for Medpace Holdings (MEDP) over the last 6 years, with Q2 2022 value amounting to $82000.0.

  • Medpace Holdings' Gains from Sales and Divestitures changed N/A to $82000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $82000.0, marking a year-over-year change of. This contributed to the annual value of $119000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q2 2022, Medpace Holdings' Gains from Sales and Divestitures is $82000.0.
  • Over the past 5 years, Medpace Holdings' Gains from Sales and Divestitures peaked at $119000.0 during Q3 2021, and registered a low of $29629.0 during Q4 2018.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $82000.0 (2022), whereas its average is $86325.8.
  • Over the last 5 years, Medpace Holdings' Gains from Sales and Divestitures had its largest YoY gain of 0.0% in 2018, and its largest YoY loss of 0.0% in 2018.
  • Over the past 3 years, Medpace Holdings' Gains from Sales and Divestitures (Quarter) stood at $29629.0 in 2018, then skyrocketed by 301.63% to $119000.0 in 2021, then crashed by 31.09% to $82000.0 in 2022.
  • Its Gains from Sales and Divestitures was $82000.0 in Q2 2022, compared to $82000.0 in Q1 2022 and $119000.0 in Q4 2021.